Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Gold

Showing results (51-60 of 700) with videos related to

Pageof 70
Sort By:
Expert Review of Neurotherapeutics|December 3, 2013
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity guidelinesRalf Gold, Celia Oreja-Guevara
Neurology|March 18, 2014
Devic disease: translational medicine at workStefan Rose-John, Ralf Gold
Der Nervenarzt|August 24, 2021
[Immunotherapy and personalized treatment of multiple sclerosis]Ralf A Linker, Ralf Gold
Journal of Neurology|September 26, 2006
Therapy of immune neuropathies with intravenous immunoglobulinsRalf Gold, Bernd C Kieseier
Journal of Neuroimmunology|October 17, 2008
Remote changes in gene expression after autoimmune demyelination: grey mattersRalf A Linker, Ralf Gold
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 21, 2008
Current and future standards in treatment of myasthenia gravisRalf Gold, Christiane Schneider-Gold
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2004
MBP-induced experimental autoimmune encephalomyelitis in C57BL/6 miceRalf A Linker, Ralf Gold
Current Opinion in Neurology|May 14, 2005
Genomics, proteomics, metabolomics: what is in a word for multiple sclerosis?Saleh M Ibrahim, Ralf Gold
The Lancet. Neurology|October 22, 2005
Towards individualised multiple-sclerosis therapyRalf Gold, Hans-Peter Hartung
The Lancet. Neurology|January 25, 2025
Therapies for myasthenia gravis: FcRn inhibition and beyondChristiane Schneider-Gold, Ralf Gold
Pageof 70

Showing results (51-60 of 700) with videos related to

Sort By:
Pageof 70
Expert Review of Neurotherapeutics|December 3, 2013
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity guidelinesRalf Gold, Celia Oreja-Guevara
Neurology|March 18, 2014
Devic disease: translational medicine at workStefan Rose-John, Ralf Gold
Der Nervenarzt|August 24, 2021
[Immunotherapy and personalized treatment of multiple sclerosis]Ralf A Linker, Ralf Gold
Journal of Neurology|September 26, 2006
Therapy of immune neuropathies with intravenous immunoglobulinsRalf Gold, Bernd C Kieseier
Journal of Neuroimmunology|October 17, 2008
Remote changes in gene expression after autoimmune demyelination: grey mattersRalf A Linker, Ralf Gold
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 21, 2008
Current and future standards in treatment of myasthenia gravisRalf Gold, Christiane Schneider-Gold
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2004
MBP-induced experimental autoimmune encephalomyelitis in C57BL/6 miceRalf A Linker, Ralf Gold
Current Opinion in Neurology|May 14, 2005
Genomics, proteomics, metabolomics: what is in a word for multiple sclerosis?Saleh M Ibrahim, Ralf Gold
The Lancet. Neurology|October 22, 2005
Towards individualised multiple-sclerosis therapyRalf Gold, Hans-Peter Hartung
The Lancet. Neurology|January 25, 2025
Therapies for myasthenia gravis: FcRn inhibition and beyondChristiane Schneider-Gold, Ralf Gold
Pageof 70